Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.
Immunol Lett
; 250: 1-6, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36108774
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Immunol Lett
Year:
2022
Document type:
Article
Affiliation country:
Austria